Nexalis Therapeutics LTD (ASX: NX1)

Sector: Health Care

Market cap: A$2M (as of 2 Nov 2026)

Australian clinical stage drug development company that is developing rapid onset therapies to address unmet medical needs in pain management and mental health sectors.

Data as of 2 Nov 2026.

Recent capital raises

Date	Type	Amount	Price	Discount	Source
17 Feb 2026	Placement	$0.15M	$0.03	—	Filing ↗
9 Dec 2025	Placement	$0.75M	$0.03	—	Filing ↗
19 Jan 2021	Other	$0.793M	$0.07	—	Filing ↗
31 Dec 2020	Rights issue	$1.565M	$0.07	—	Filing ↗
4 Nov 2020	Placement	$0.721M	$0.06	—	Filing ↗

Substantial holders — latest moves

Date	Holder	Move	Holding	Source
30 July 2026	NIV DAGAN, 10 BOLIVANOS PTY LTD, FREEDOM TRADER PTY LTD	Increase	11.38% → 14.81%	Filing ↗
31 Mar 2026	CANNVALATE PTY LTD	Entry	?% → 19.1%	Filing ↗
9 Dec 2025	—	Unknown	—	Filing ↗
19 Aug 2021	Niv Dagan, Freedom Trader Pty Ltd and 10 Bolivianos Pty Ltd	Increase	7.14% → 8.85%	Filing ↗
20 Jan 2021	Ela Capital Inc.	Entry	?% → 8.6%	Filing ↗

Director trades — on-market

Date	Director	Trade	Source
11 Aug 2021	Darryl Davies	Bought 1,025,000	Filing ↗
21 July 2021	Darryl Davies	Bought 1,007,000	Filing ↗
25 Nov 2019	Rodney Hannington	Bought 132,267	Filing ↗
31 Oct 2019	Rodney Hannington	Bought 100,000	Filing ↗

Cash and runway

Metric	Value	As of	Source
Cash	A$371K	30 Sept 2026	Filing ↗
Runway	0.9 quarters	30 Sept 2026	Filing ↗

Ask about NX1 in Claude or ChatGPT

Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:

Has NX1 raised money in the last year, and at what discount?
What was NX1's latest cash position and runway?

Setup guide for Claude, ChatGPT and other MCP clients →

Loading NX1…